世界の制限エンドヌクレアーゼ製品市場予測2022-2028:I型酵素、II型酵素、III型酵素、IV型酵素

【英語タイトル】Restriction Endonucleases Product Market, Global Outlook and Forecast 2022-2028

Market Monitor Globalが出版した調査資料(MMG22NV12775)・商品コード:MMG22NV12775
・発行会社(調査会社):Market Monitor Global
・発行日:2022年11月
・ページ数:75
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:製薬・ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の制限エンドヌクレアーゼ製品市場規模と予測を収録しています。・世界の制限エンドヌクレアーゼ製品市場:売上、2017年-2022年、2023年-2028年
・世界の制限エンドヌクレアーゼ製品市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

世界の制限エンドヌクレアーゼ製品市場は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「I型酵素」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

制限エンドヌクレアーゼ製品のグローバル主要企業は、Agilent Technologies, Inc.、 Thermo Fisher Scientific Inc.、 Affymetrix, Inc.、 Illumina, Inc.、 Enzymatics, Inc.、 QIAGEN N.V.、 New England Biolabs, Inc.、 Sigma-Aldrich Co. LLC.、 Roche, Ltd.、 Takara Bio, Incなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、制限エンドヌクレアーゼ製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の制限エンドヌクレアーゼ製品市場:タイプ別、2017年-2022年、2023年-2028年
世界の制限エンドヌクレアーゼ製品市場:タイプ別市場シェア、2021年
・I型酵素、II型酵素、III型酵素、IV型酵素

世界の制限エンドヌクレアーゼ製品市場:用途別、2017年-2022年、2023年-2028年
世界の制限エンドヌクレアーゼ製品市場:用途別市場シェア、2021年
・病院、診療所、薬局、その他

世界の制限エンドヌクレアーゼ製品市場:地域・国別、2017年-2022年、2023年-2028年
世界の制限エンドヌクレアーゼ製品市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における制限エンドヌクレアーゼ製品のグローバル売上、2017年-2022年
・主要企業における制限エンドヌクレアーゼ製品のグローバル売上シェア、2021年
・主要企業における制限エンドヌクレアーゼ製品のグローバル販売量、2017年-2022年
・主要企業における制限エンドヌクレアーゼ製品のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Agilent Technologies, Inc.、 Thermo Fisher Scientific Inc.、 Affymetrix, Inc.、 Illumina, Inc.、 Enzymatics, Inc.、 QIAGEN N.V.、 New England Biolabs, Inc.、 Sigma-Aldrich Co. LLC.、 Roche, Ltd.、 Takara Bio, Inc

*************************************************************

・調査・分析レポートの概要
制限エンドヌクレアーゼ製品市場の定義
市場セグメント
世界の制限エンドヌクレアーゼ製品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の制限エンドヌクレアーゼ製品市場規模
世界の制限エンドヌクレアーゼ製品市場規模:2021年 VS 2028年
世界の制限エンドヌクレアーゼ製品市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの制限エンドヌクレアーゼ製品の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の制限エンドヌクレアーゼ製品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:I型酵素、II型酵素、III型酵素、IV型酵素
制限エンドヌクレアーゼ製品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、診療所、薬局、その他
制限エンドヌクレアーゼ製品の用途別グローバル売上・予測

・地域別市場分析
地域別制限エンドヌクレアーゼ製品市場規模 2021年と2028年
地域別制限エンドヌクレアーゼ製品売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Agilent Technologies, Inc.、 Thermo Fisher Scientific Inc.、 Affymetrix, Inc.、 Illumina, Inc.、 Enzymatics, Inc.、 QIAGEN N.V.、 New England Biolabs, Inc.、 Sigma-Aldrich Co. LLC.、 Roche, Ltd.、 Takara Bio, Inc
...

Restriction endonucleases are also known as the restriction enzyme. Restriction Endonucleases is a process included in the reaction mixture that cuts the unmodified DNA strand at a Double-stranded hemiphophorothioate recognition site, which occurs when the 5’-[a-thio] triphosphate nucleotide is incorporated.Restriction enzymes are traditionally classified into four types on the basis of subunit composition, cleavage position, sequence specificity and cofactor requirements. However, amino acid sequencing has uncovered extraordinary variety among restriction enzymes and revealed that at the molecular level, there are many more than four different types.
This report contains market size and forecasts of Restriction Endonucleases Product in global, including the following market information:
Global Restriction Endonucleases Product Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Restriction Endonucleases Product Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Restriction Endonucleases Product companies in 2021 (%)
The global Restriction Endonucleases Product market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Type I Enzymes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Restriction Endonucleases Product include Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Affymetrix, Inc., Illumina, Inc., Enzymatics, Inc., QIAGEN N.V., New England Biolabs, Inc., Sigma-Aldrich Co. LLC. and Roche, Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Restriction Endonucleases Product manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Restriction Endonucleases Product Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Restriction Endonucleases Product Market Segment Percentages, by Type, 2021 (%)
Type I Enzymes
Type II Enzymes
Type III Enzymes
Type IV Enzymes
Global Restriction Endonucleases Product Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Restriction Endonucleases Product Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Pharmacy
Others
Global Restriction Endonucleases Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Restriction Endonucleases Product Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Restriction Endonucleases Product revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Restriction Endonucleases Product revenues share in global market, 2021 (%)
Key companies Restriction Endonucleases Product sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Restriction Endonucleases Product sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc.
Affymetrix, Inc.
Illumina, Inc.
Enzymatics, Inc.
QIAGEN N.V.
New England Biolabs, Inc.
Sigma-Aldrich Co. LLC.
Roche, Ltd.
Takara Bio, Inc

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Restriction Endonucleases Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Restriction Endonucleases Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Restriction Endonucleases Product Overall Market Size
2.1 Global Restriction Endonucleases Product Market Size: 2021 VS 2028
2.2 Global Restriction Endonucleases Product Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Restriction Endonucleases Product Sales: 2017-2028
3 Company Landscape
3.1 Top Restriction Endonucleases Product Players in Global Market
3.2 Top Global Restriction Endonucleases Product Companies Ranked by Revenue
3.3 Global Restriction Endonucleases Product Revenue by Companies
3.4 Global Restriction Endonucleases Product Sales by Companies
3.5 Global Restriction Endonucleases Product Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Restriction Endonucleases Product Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Restriction Endonucleases Product Product Type
3.8 Tier 1, Tier 2 and Tier 3 Restriction Endonucleases Product Players in Global Market
3.8.1 List of Global Tier 1 Restriction Endonucleases Product Companies
3.8.2 List of Global Tier 2 and Tier 3 Restriction Endonucleases Product Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Restriction Endonucleases Product Market Size Markets, 2021 & 2028
4.1.2 Type I Enzymes
4.1.3 Type II Enzymes
4.1.4 Type III Enzymes
4.1.5 Type IV Enzymes
4.2 By Type – Global Restriction Endonucleases Product Revenue & Forecasts
4.2.1 By Type – Global Restriction Endonucleases Product Revenue, 2017-2022
4.2.2 By Type – Global Restriction Endonucleases Product Revenue, 2023-2028
4.2.3 By Type – Global Restriction Endonucleases Product Revenue Market Share, 2017-2028
4.3 By Type – Global Restriction Endonucleases Product Sales & Forecasts
4.3.1 By Type – Global Restriction Endonucleases Product Sales, 2017-2022
4.3.2 By Type – Global Restriction Endonucleases Product Sales, 2023-2028
4.3.3 By Type – Global Restriction Endonucleases Product Sales Market Share, 2017-2028
4.4 By Type – Global Restriction Endonucleases Product Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Restriction Endonucleases Product Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Pharmacy
5.1.5 Others
5.2 By Application – Global Restriction Endonucleases Product Revenue & Forecasts
5.2.1 By Application – Global Restriction Endonucleases Product Revenue, 2017-2022
5.2.2 By Application – Global Restriction Endonucleases Product Revenue, 2023-2028
5.2.3 By Application – Global Restriction Endonucleases Product Revenue Market Share, 2017-2028
5.3 By Application – Global Restriction Endonucleases Product Sales & Forecasts
5.3.1 By Application – Global Restriction Endonucleases Product Sales, 2017-2022
5.3.2 By Application – Global Restriction Endonucleases Product Sales, 2023-2028
5.3.3 By Application – Global Restriction Endonucleases Product Sales Market Share, 2017-2028
5.4 By Application – Global Restriction Endonucleases Product Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Restriction Endonucleases Product Market Size, 2021 & 2028
6.2 By Region – Global Restriction Endonucleases Product Revenue & Forecasts
6.2.1 By Region – Global Restriction Endonucleases Product Revenue, 2017-2022
6.2.2 By Region – Global Restriction Endonucleases Product Revenue, 2023-2028
6.2.3 By Region – Global Restriction Endonucleases Product Revenue Market Share, 2017-2028
6.3 By Region – Global Restriction Endonucleases Product Sales & Forecasts
6.3.1 By Region – Global Restriction Endonucleases Product Sales, 2017-2022
6.3.2 By Region – Global Restriction Endonucleases Product Sales, 2023-2028
6.3.3 By Region – Global Restriction Endonucleases Product Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Restriction Endonucleases Product Revenue, 2017-2028
6.4.2 By Country – North America Restriction Endonucleases Product Sales, 2017-2028
6.4.3 US Restriction Endonucleases Product Market Size, 2017-2028
6.4.4 Canada Restriction Endonucleases Product Market Size, 2017-2028
6.4.5 Mexico Restriction Endonucleases Product Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Restriction Endonucleases Product Revenue, 2017-2028
6.5.2 By Country – Europe Restriction Endonucleases Product Sales, 2017-2028
6.5.3 Germany Restriction Endonucleases Product Market Size, 2017-2028
6.5.4 France Restriction Endonucleases Product Market Size, 2017-2028
6.5.5 U.K. Restriction Endonucleases Product Market Size, 2017-2028
6.5.6 Italy Restriction Endonucleases Product Market Size, 2017-2028
6.5.7 Russia Restriction Endonucleases Product Market Size, 2017-2028
6.5.8 Nordic Countries Restriction Endonucleases Product Market Size, 2017-2028
6.5.9 Benelux Restriction Endonucleases Product Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Restriction Endonucleases Product Revenue, 2017-2028
6.6.2 By Region – Asia Restriction Endonucleases Product Sales, 2017-2028
6.6.3 China Restriction Endonucleases Product Market Size, 2017-2028
6.6.4 Japan Restriction Endonucleases Product Market Size, 2017-2028
6.6.5 South Korea Restriction Endonucleases Product Market Size, 2017-2028
6.6.6 Southeast Asia Restriction Endonucleases Product Market Size, 2017-2028
6.6.7 India Restriction Endonucleases Product Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Restriction Endonucleases Product Revenue, 2017-2028
6.7.2 By Country – South America Restriction Endonucleases Product Sales, 2017-2028
6.7.3 Brazil Restriction Endonucleases Product Market Size, 2017-2028
6.7.4 Argentina Restriction Endonucleases Product Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Restriction Endonucleases Product Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Restriction Endonucleases Product Sales, 2017-2028
6.8.3 Turkey Restriction Endonucleases Product Market Size, 2017-2028
6.8.4 Israel Restriction Endonucleases Product Market Size, 2017-2028
6.8.5 Saudi Arabia Restriction Endonucleases Product Market Size, 2017-2028
6.8.6 UAE Restriction Endonucleases Product Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Corporate Summary
7.1.2 Agilent Technologies, Inc. Business Overview
7.1.3 Agilent Technologies, Inc. Restriction Endonucleases Product Major Product Offerings
7.1.4 Agilent Technologies, Inc. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.1.5 Agilent Technologies, Inc. Key News
7.2 Thermo Fisher Scientific Inc.
7.2.1 Thermo Fisher Scientific Inc. Corporate Summary
7.2.2 Thermo Fisher Scientific Inc. Business Overview
7.2.3 Thermo Fisher Scientific Inc. Restriction Endonucleases Product Major Product Offerings
7.2.4 Thermo Fisher Scientific Inc. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.2.5 Thermo Fisher Scientific Inc. Key News
7.3 Affymetrix, Inc.
7.3.1 Affymetrix, Inc. Corporate Summary
7.3.2 Affymetrix, Inc. Business Overview
7.3.3 Affymetrix, Inc. Restriction Endonucleases Product Major Product Offerings
7.3.4 Affymetrix, Inc. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.3.5 Affymetrix, Inc. Key News
7.4 Illumina, Inc.
7.4.1 Illumina, Inc. Corporate Summary
7.4.2 Illumina, Inc. Business Overview
7.4.3 Illumina, Inc. Restriction Endonucleases Product Major Product Offerings
7.4.4 Illumina, Inc. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.4.5 Illumina, Inc. Key News
7.5 Enzymatics, Inc.
7.5.1 Enzymatics, Inc. Corporate Summary
7.5.2 Enzymatics, Inc. Business Overview
7.5.3 Enzymatics, Inc. Restriction Endonucleases Product Major Product Offerings
7.5.4 Enzymatics, Inc. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.5.5 Enzymatics, Inc. Key News
7.6 QIAGEN N.V.
7.6.1 QIAGEN N.V. Corporate Summary
7.6.2 QIAGEN N.V. Business Overview
7.6.3 QIAGEN N.V. Restriction Endonucleases Product Major Product Offerings
7.6.4 QIAGEN N.V. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.6.5 QIAGEN N.V. Key News
7.7 New England Biolabs, Inc.
7.7.1 New England Biolabs, Inc. Corporate Summary
7.7.2 New England Biolabs, Inc. Business Overview
7.7.3 New England Biolabs, Inc. Restriction Endonucleases Product Major Product Offerings
7.7.4 New England Biolabs, Inc. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.7.5 New England Biolabs, Inc. Key News
7.8 Sigma-Aldrich Co. LLC.
7.8.1 Sigma-Aldrich Co. LLC. Corporate Summary
7.8.2 Sigma-Aldrich Co. LLC. Business Overview
7.8.3 Sigma-Aldrich Co. LLC. Restriction Endonucleases Product Major Product Offerings
7.8.4 Sigma-Aldrich Co. LLC. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.8.5 Sigma-Aldrich Co. LLC. Key News
7.9 Roche, Ltd.
7.9.1 Roche, Ltd. Corporate Summary
7.9.2 Roche, Ltd. Business Overview
7.9.3 Roche, Ltd. Restriction Endonucleases Product Major Product Offerings
7.9.4 Roche, Ltd. Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.9.5 Roche, Ltd. Key News
7.10 Takara Bio, Inc
7.10.1 Takara Bio, Inc Corporate Summary
7.10.2 Takara Bio, Inc Business Overview
7.10.3 Takara Bio, Inc Restriction Endonucleases Product Major Product Offerings
7.10.4 Takara Bio, Inc Restriction Endonucleases Product Sales and Revenue in Global (2017-2022)
7.10.5 Takara Bio, Inc Key News
8 Global Restriction Endonucleases Product Production Capacity, Analysis
8.1 Global Restriction Endonucleases Product Production Capacity, 2017-2028
8.2 Restriction Endonucleases Product Production Capacity of Key Manufacturers in Global Market
8.3 Global Restriction Endonucleases Product Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Restriction Endonucleases Product Supply Chain Analysis
10.1 Restriction Endonucleases Product Industry Value Chain
10.2 Restriction Endonucleases Product Upstream Market
10.3 Restriction Endonucleases Product Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Restriction Endonucleases Product Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界の制限エンドヌクレアーゼ製品市場予測2022-2028:I型酵素、II型酵素、III型酵素、IV型酵素] (コード:MMG22NV12775)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の制限エンドヌクレアーゼ製品市場予測2022-2028:I型酵素、II型酵素、III型酵素、IV型酵素]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆